glp-1 gip mechanism of action How May Enhance the Therapeutic Efficacy GLP-1? GLP-1 Therapy Part 1: Setting

However, athletes considering these medications primarily for body composition changes (rather than health-related weight loss) should understand that muscle preservation requires deliberate, intensive effort

Our medical team will review possible side effects, how to manage them, and monitor your progress to ensure your safety

Published 2025 Apr 14

Multi-dimensional formula addresses the facial changes that occur when using GLP-1 agonists Formula works in 4D to improve the appearance of facial skin deflation, loose, sagging, crepey skin texture, dehydration, and deep wrinkles Proprietary XOSM technology boosts formula performance Improves the appearance of skin firmness, density and skin texture quality Deeply nourishes and hydrates, plumping the skin Protects and nourishes the skins barrier 20.1% increase in facial volume 22.5% increase in firmness 23.2% increase in net elasticity 20.7% decrease in wrinkles 21.8% increase in hydration Disclaimer: Based on a 12-week clinical study of 29 participants ages 3565, who have experienced weight loss due to the use of one of the following: GLP-1 agonists, GIP, other weight loss promoting drugs or gastric bypass surgery, with twice daily application of VOL.U.LIFT

In some instances, the symptoms resolved within a few weeks as the body reached a state of steady-state with the medication